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INTRODUCTION 
 
Welcome to the first Poison Center & Public Health Collaboration 
Community of Practice (CoP) Newsletter! With over 200 members 
from state and local health departments, poison centers, and 
federal agencies, the Poison Center & Public Health Collaboration 
CoP is a diverse group of professionals actively involved and 
interested in poison center and public health collaboration. If 
there is a particular topic about which you want to hear more, 
please let us know. We want the CoP group and newsletter to be 
an open forum for sharing and discussion. Please use our 
community email list for this interaction.  
 
HISTORY  
 
Data collected by the nation’s 55 poison centers (PCs) are an 
important tool for all-hazards exposure and illness surveillance. 
Close collaboration and open communication among local, state, 
and federal public health partners and PCs is necessary to 
leverage PC data for public health surveillance.  
In 2010, the Council of State and Territorial Epidemiologists, 
(CSTE), American Association of Poison Control Centers (AAPCC), 
and the Centers for Disease Control and Prevention’s Health 
Studies Branch spearheaded the creation of the Poison Center & 
Public Health Collaboration CoP.  
 
Mission: To bolster collaboration between federal, state, and 
local health agencies and departments and PCs through sharing 
best practices and facilitating networking between members. 
 
Successes: 
• More than 200 public health and poison center 
professionals have joined 
• Steering committee established  
• 14 national webinars conducted 
• Six roundtable discussions at national meetings held 
• Special projects focused on supporting partnerships 
between health departments (HDs) and PCs conducted 
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CoP Steering Committee 
Composed of representatives from 
PCs, state DOHs, and CDC. The 
committee sets objectives and 
provides guidance on the activities 
and direction of the CoP.  
 
Community Co-Chairs: Jay Schauben 
& Martha Stanbury 
 
Community Committee members: 
Melissa Powell; Philip Cavicchia; 
Patrick Young; Prakash Mulay; Timur 
Durrani; Maria Mercurio-Zappala; 
Michele Caliva  
 
Community Facilitators: Rebecca 
Lyons & Royal Law 
 
UPCOMING EVENTS 
 
Webinar 
February 10, 2016—3:30-4:30PM EST 
 
Topic: “Virginia: Department of Health & Poison Center 
Collaboration in the Spring 2015 Clenbuterol-Adulterated Heroin 
Outbreak” 
 
Presenters: Brigette Gleason, MD, MPH (Virginia Department of 
Health) and Kirk Cumpston, DO, FACEP, FACMT (Virginia Poison 
Center) 
 
 
FEATURED TOPIC  
 
Synthetic cannabinoids are various psychoactive chemicals or a mixture of chemicals that are often sprayed onto 
plant material, which is then smoked or ingested to achieve a “high.” These products are sold under a variety of 
names (e.g., “synthetic marijuana,” “spice,” “K2,” “black mamba,” and “crazy clown”) and may be sold in retail 
outlets as herbal products. Law enforcement agencies have regulated a number of these substances. However, 
manufacturers of synthetic cannabinoids frequently change the formulation to avoid detection and regulation. 
 
Synthetic cannabinoids (SCs) are featured in this issue because they are associated with local outbreaks of 
adverse health effects that have occurred across the country. These features highlight collaborations between PCs 
and public health agencies. 
 
FEATURED ARTICLES:  PUBLIC HEALTH & POISON CENTER COLLABORATIONS FOR SYNTHETIC 
CANNABINOID SURVEILLANCE  
 
STATE & PUBLIC HEALTH COLLABORATION 
MISSISSIPPI OUTBREAK 
Summary of: Kasper et. al (2015). Notes from the Field: Severe 
Illness Associated with Reported Use of Synthetic 
Cannabinoids—Mississippi—April 2015. MMWR (October 9, 
2015). 
The largest outbreak of synthetic cannabinoid-associated adverse 
health events ever recorded was in Mississippi in April 2015. The 
Mississippi (MS) State Department of Health, with the assistance 
of CDC, conducted an investigation to characterize the outbreak 
better, to identify risk factors associated with severe illness, and 
to prevent additional illnesses and deaths. 
 
 
 
 
 
 
 
Access the full article at: 
http://www.cdc.gov/mmwr/preview/mmwrhtml/
mm6439a7.htm 
 
 
Adverse Health Effects - University of 
Mississippi Medical Center (N = 119) 
• Tachycardia (48/115, 42%) 
• Elevated systolic blood pressure 
(35/115, 30%) 
• Aggressive or violent behavior 
(38/119, 32%) 
• Confusion (30/119, 25%) 
• Significant associations between 
previous medical history of mental 
illness or substance abuse and more 
severe outcomes 
 
Statewide – PCs 721 reports  
Study-specific – 119 cases seen at 
UMMC  
• Majority male (101/119, 85%) 
• Median age 31 (range 14-62 years) 
 
 
Share your Experience! 
We’d love to hear about your 
experiences collaborating with your 
local PC or DOH on surveillance! 
For more details on how you can present a 
webinar please contact Rebecca Lyons at 
RLyons@cdc.gov 
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CDC & PC COLLABORATIONS  
NATIONWIDE INCREASE  
Summary of: Law et. al (2015). Notes from the Field: Increase in 
Reported Adverse Health Effects Related to Synthetic 
Cannabinoid Use—United States, January-May 2015. MMWR 
(June 12, 2015). 
CDC collaborated with American Association of Poison Control 
Centers (AAPCC) to analyze information from the National Poiso
Data System on reported adverse health effects nationwide 
related to synthetic cannabinoid use for the period of January-
May 2015. During this period poison centers reported 3,572 call
related to synthetic cannabinoid use, a 229% increase from 1,08
calls during the same period in 2014 (see figure). 
Figure. Number of calls to PCs reporting adverse health effects from 
synthetic cannabinoids, by week 
 
 
 
 
 
 
 
 
 
 
Trends—Nationwide (N=3,572) 
• Majority male (2,882, 80.7%)  
• Median age 26 (range 7 months to 
72 years) 
• Common routes of exposure: 
o Inhalation (2,870, 80.3%) 
o Ingestion (698, 19.5%) 
• 626 (17.5%) reported use with 
multiple substances 
o Alcohol (144, 23.0%) 
o Plant Derived Marijuana (103, 
16.5%) 
o Benzodiazepines (69, 11.0%)  
Adverse Health Effects—Nationwide  
• Agitation (1,262, 35.4%) 
• Tachycardia (1,035, 29.0%) 
• Drowsiness or lethargy (939, 26.3%) 
• Vomiting (585, 16.4%) 
• Confusion (506, 15%) 
  
 
 
 
 
 
   
  
 
 
 
 
 
 
 
 
 
   
Access the full article at: 
http://www.cdc.gov/mmwr/preview/mmwrhtml/
mm6422a5.htm  
For More Information on SCs: 
Visit the AAPCC synthetic cannabinoids 
page, http://www.aapcc.org/alerts/sythetic-
cannabinoids/ 
 
We would like to hear about any experiences your service area or jurisdiction has had 
responding to increases in synthetic cannabinoid cases and any thoughts you have on how 
poison centers and public health agencies can partner to improve surveillance of synthetic 
cannabinoids. Please email your thoughts to Rebecca Lyons at RLyons@cdc.gov. 
CoP Partners: 
http://www.cdc.gov/nceh/hsb/ 
American Association of 
Poison Control Centers 
http://www.aapcc.org/ 
Council of State & Territorial 
Epidemiologists 
http://www.cste.org/ 
U.S. Department of Health and Human Services 
Centers for Disease Control and Prevention 
National Center for Environmental Health—Health Studies Branch 
E-mail: RLyons@cdc.gov | Web: http://www.cdc.gov/nceh/hsb/chemicals/poison_center.htm  
